Cargando…
Expression of the hypermethylated in cancer gene (HIC-1) is associated with good outcome in human breast cancer
A new cancer gene, HIC-1 (Hypermethylated in Cancer) telomeric to p53 on chromosome 17p may be of clinical importance in sporadic breast cancer. Regional DNA hypermethylation of 17p13.3 resulting in suppression of gene expression has been shown to precede 17p structural changes in human carcinogenes...
Autores principales: | Nicoll, G, Crichton, D N, McDowell, H E, Kernohan, N, Hupp, T R, Thompson, A M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363999/ https://www.ncbi.nlm.nih.gov/pubmed/11747329 http://dx.doi.org/10.1054/bjoc.2001.2163 |
Ejemplares similares
-
Differential p53 protein expression in breast cancer fine needle aspirates: the potential for in vivo monitoring
por: Ball, H M-L, et al.
Publicado: (2001) -
Hypermethylation of the HIC1 promoter and aberrant expression of HIC1/SIRT1 contribute to the development of thyroid papillary carcinoma
por: Wu, Wenyi, et al.
Publicado: (2016) -
Genomic deletion and promoter methylation status of Hypermethylated in Cancer 1 (HIC1) in mantle cell lymphoma
por: Stöcklein, Heike, et al.
Publicado: (2008) -
Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers
por: Jin, Z, et al.
Publicado: (2001) -
HIC1 (Hypermethylated in Cancer 1) modulates the contractile activity of prostate stromal fibroblasts and directly regulates CXCL12 expression
por: Dubuissez, Marion, et al.
Publicado: (2020)